학술논문
Treatment rationale and protocol design: an investigator-initiated phase II study of combination treatment of nivolumab and TM5614, a PAI-1 inhibitor for previously treated patients with non-small cell lung cancer
Document Type
Article
Author
Source
In: Journal of Thoracic Disease . (Journal of Thoracic Disease, 31 May 2024, 16(5):3381-3388)
Subject
Language
English
ISSN
20776624
20721439
20721439